Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea.
Su Jin ChoiSoo Min AhnJi Seon OhSeokchan HongChang-Keun LeeBin YooByong Duk YeSuk-Kyun YangSang Hyoung ParkYong-Gil KimPublished in: Therapeutic advances in gastroenterology (2021)
Although rare, ATIL is associated with poor treatment response to IBD in Korean patients. ATIL should be considered if arthritis and mucocutaneous symptoms develop during anti-TNF therapy for IBD.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- patients with inflammatory bowel disease
- chronic kidney disease
- newly diagnosed
- systemic lupus erythematosus
- ejection fraction
- disease activity
- peritoneal dialysis
- prognostic factors
- high glucose
- diabetic rats
- patient reported outcomes
- sleep quality
- endothelial cells
- oxidative stress
- drug induced